Laura Brege, Director at Pacira BioSciences, Inc. (PCRX), sold 600 shares at $38.74 ($23K) on 2023-06-05, disclosed to the SEC on 2023-06-07.
Scheduled sale ($23k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-04-05 | $285K | — | Filing → |